81569-25-7

Basic information

• Product Name: METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE
• Synonyms: METHYL 2-AMINO-5-ISOPROPYLTHIAZOLE-4-CARBOXYLATE;METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE;4-Thiazolecarboxylicacid,2-amino-5-(1-methylethyl)-,methylester(9CI);Methyl 2-amino-5-(prop-2-yl)-1,3-thiazole-4-carboxylate, 2-Amino-5-isopropyl-4-(methoxycarbonyl)-1,3-thiazole;Methyl 2-aMino-5-(propan-2-yl)-1,3-thiazole-4-carboxylate;1W-0612;2-amino-5-isopropyl-4-thiazolecarboxylic acid methyl ester;2-amino-5-isopropyl-thiazole-4-carboxylic acid methyl ester
• CAS NO: 81569-25-7
• Molecular Formula: C₈H₁₂N₂O₂S
• Molecular Weight: 200.26
• Product Categories: AMINOACID
• Mol File: 81569-25-7.mol
• Article Data: 10

Chemical Properties

• Melting Point: 150-152°C
• Boiling Point: 337.1 °C at 760 mmHg
• Flash Point: 157.7 °C
• Appearance: /
• Density: 1.233 g/cm³
• Vapor Pressure: 0.000107mmHg at 25°C
• Refractive Index: 1.565
• Storage Temp.: 2-8°C
• PKA: 2.84±0.10(Predicted)
• CAS DataBase Reference: METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE(81569-25-7)
• EPA Substance Registry System: METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE(81569-25-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 81569-25-7(Hazardous Substances Data)

Usage

General Description

METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE is a chemical compound with the molecular formula C9H15N3O2S. It is a thiazole derivative that contains an amino group and a carboxylate group. METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE is commonly used as a building block in organic synthesis and pharmaceutical research. It has potential applications in the development of new drugs and agrochemicals due to its unique structural properties. METHYL 2-AMINO-5-ISOPROPYL-1,3-THIAZOLE-4-CARBOXYLATE is a valuable chemical in the field of medicinal chemistry and drug discovery.

InChI:InChI=1/C8H12N2O2S/c1-4(2)6-5(7(11)12-3)10-8(9)13-6/h4H,1-3H3,(H2,9,10)

Upstream product

• 116-54-1 dichloroacetic acid methyl ester 
• 17356-08-0 thiourea 
• 78-84-2 isobutyraldehyde 
• 67-56-1 methanol 
• 535-15-9 ethyl 1,1-dichloroacetate 
• 50652-78-3 methyl 4-methylpent-2-enoate 
• 28942-47-4 methyl 2-chloro-3-isopropyloxirane-2-carboxylate 

Downstream Products

• 81569-26-8 5-isopropyl-thiazole-4-carboxylic acid methyl ester 
• 81569-27-9 methyl 2-chloro-5-isopropylthiazole-4-carboxylate 
• 81569-28-0 methyl 2-bromo-5-isopropyl-thiazole-4-carboxylate 
• 566947-06-6 methyl 5-isopropyl-2-[(3-methoxybenzoyl)amino]-1,3-thiazole-4-carboxylate 
• 804482-42-6 methyl 5-isopropyl-2-{[(3-nitrophenyl)sulfonyl]amino}-1,3-thiazole-4-carboxylate 
• 566947-07-7 5-isopropyl-2-[(3-methoxybenzoyl)amino]-1,3-thiazole-4-carboxylic acid 
• 1231955-39-7 methyl 5-isopropyl-2-{[2-fluoro-5-(trifluoromethyl)benzoyl]amino}-1,3-thiazole-4-carboxylate 

Relevant articles and documents

Investigation of the factors that dictate the preferred orientation of lexitropsins in the minor groove of DNA

Lexitropsins are small molecules that bind to the minor groove of DNA as antiparallel dimers in a specific orientation. These molecules have shown therapeutic potential in the treatment of several diseases; however, the development of these molecules to target particular genes requires revealing the factors that dictate their preferred orientation in the minor grooves, which to date have not been investigated. In this study, a distinct structure (thzC) was carefully designed as an analog of a well-characterized lexitropsin (thzA) to reveal the factors that dictate the preferred binding orientation. Comparative evaluations of the biophysical and molecular modeling results of both compounds showed that the position of the dimethylaminopropyl group and the orientation of the amide links of the ligand with respect to the 5′-3′-ends; dictate the preferred orientation of lexitropsins in the minor grooves. These findings could be useful in the design of novel lexitropsins to selectively target specific genes.

ACYLAMINOTHIAZOLE DERIVATIVES AND USE THEREOF AS BETA-AMYLOID INHIBITORS

Compounds of formula (I) as defined herein: inhibit the formation of the β-amyloid peptide (β-A4) and are, therefore, useful in the treatment of pathologies in which a β-amyloid peptide (β-A4) formation inhibitor provides a therapeutic benefit. Particular

Identification of potent type I MetAP inhibitors by simple bioisosteric replacement. Part 1: Synthesis and preliminary SAR studies of thiazole-4-carboxylic acid thiazol-2-ylamide derivatives

A series of thiazole-4-carboxylic acid thiazol-2-ylamide (TCAT, 4) derivatives were designed and synthesized according to simple bioisosteric replacement from previously reported pyridine-2-carboxylic acid thiazol-2-ylamide (PCAT) MetAP inhibitors. The preliminary SAR studies demonstrated that these TCAT series of compounds showed different activity and selectivity compared with those of the corresponding PCAT compounds. These findings provide useful information for the design and discovery of more potent inhibitors of type I MetAPs.